diabetes glp 1 agonist Glucagon-like peptide-1 Understanding GLP-1 receptor agonists and

Clinical trials have shown that GLP-1R agonists increase microvascular blood volume and flow in cardiac muscle, and these effects are preserved in obese individuals with vascular insulin resistance

These medications slow gastric emptying, enhance insulin secretion in response to glucose, and signal satiety to the brain's appetite centers

The real question is whether this space will mature into a legitimate, responsible arm of obesity medicine or be dismissed as a chaotic market of pill mills

How is your energy

For broader regulatory context, see FDA Peptide Reclassification 2026: What It Means for Canadian Researchers

Do I still need metformin after starting a GLP-1 injection